Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Ossium Health, Inc.
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Washington
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Pfizer
M.D. Anderson Cancer Center
Therapeutic Advances in Childhood Leukemia Consortium
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
University of Washington
Masonic Cancer Center, University of Minnesota
Children's Oncology Group
German CLL Study Group
Washington University School of Medicine
Cellerant Therapeutics
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
University of Kentucky
Columbia University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Northwestern University
Northwestern University
Garden State Cancer Center at the Center for Molecular Medicine and Immunology
Temple University
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center